Trial Profile
Safety and Efficacy of an Inactivated and Non Adjuvanted Vaccine Against Influenza A in Renal Transplant Recipients.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Feb 2017
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- Acronyms Transfluvac
- 28 Jul 2010 New trial record